Centers for Disease Control and Prevention (CDC) Offers Guidance for HIV Prophylaxis

MedPageToday -- So-called pre-exposure prophylaxis (PrEP) for HIV appears safe and at least partly effective, but clinicians and patients need to take care to avoid possible problems, the CDC said in an interim guidance. A recent study showed that taking a daily antiretroviral pill containing two drugs could significantly reduce the risk of acquiring HIV, the agency noted in the Jan. 28 issue of Morbidity and Mortality Weekly Report.